The biotech industry displayed remarkable resilience in 2024, with top-performing stocks being led by companies like Bright Minds Biosciences, Monopar Therapeutics, and Summit Therapeutics. The key drivers for strong stock performance last year were regulatory approval, medical breakthroughs, and successful clinical trials progress. Notable emerging trends in 2024 included therapies inspired by psychedelics, radiopharmaceuticals, advancements in gene-related therapies, and the rise of bispecific antibodies in the field of cancer treatment.
ESET Wins Four Global InfoSec Awards at RSAC 2026
ESET announced that it has won four Global InfoSec Awards from Cyber Defense Magazine (CDM), the industry’s leading electronic information security magazine. Now in its thirteenth
